Patents News - Candlesense

Rail Vision Receives European Patent for Innovative Locomotive Imaging Technology

Ra’anana, Israel, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the “Company”), an early commercialization stage technology company seeking to revolutionize ...

How might this development influence analyst coverage and earnings estimates for Rail Vision? Will the company need additional capital to bring this technology to market, and how could that impact dilution? What is the estimated size of the target market for high‑resolution railway imaging systems?

Symbol: RVSN

14 days ago

Read more globenewswire

Avicanna Announces US Patent and Trademark Office Issuance of New Patent

USPTO Issues Patent No. US 12,343,315 B2 covering topical cannabinoid compositions for clear skin

What is the expected timeline for bringing products based on this patent to market and how will that timeline affect short‑term trading opportunities? Are there any regulatory or litigation risks tied to the commercialization of this topical cannabinoid composition? How might the patent influence analyst coverage and target price revisions for Avicanna?

Symbol: AVCN

14 days ago

Read more globenewswire

SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

TEL AVIV, Israel, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therap...

What is the potential impact on SciSparc's pipeline diversification and overall risk profile? How does the announced therapy compare to existing treatments for obesity and high blood sugar in terms of efficacy and safety? Are there any regulatory or safety concerns that could delay or jeopardize the development of the novel combination therapy?

Symbol: SPRC

18 days ago

Read more globenewswire

Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

Vancouver, Canada, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and ...

Could this news trigger short-term volatility or a sustained price movement in Clearmind's stock? What are the projected costs and funding requirements for advancing this therapy through Phase 2 and Phase 3 trials? How does this development compare to similar pipelines of competitors in the CNS and metabolic space?

Symbol: CMND

18 days ago

Read more globenewswire

Bone Solutions Announces Five New Patents Awarded in FY25, Further Enhancing Its Core Mg OSTEOCRETE Technology

COLLEYVILLE, Texas--(BUSINESS WIRE)-- #BoneSolutions--Bone Solutions Inc., an orthobiologics technology company located in Colleyville, Texas, announced today its fifth patent awarded this year fro...

What risks exist if the patents are challenged, invalidated, or fail to gain clinical adoption? How might the patents affect the company’s valuation multiples (P/E, EV/EBITDA) compared to peers? What is the expected impact on the company's R&D and CapEx budgets?

Symbol: BONE

20 days ago

Prevencio Awarded U.S., European and Japanese Patents for HART CADhs, Its AI-Driven Blood Test for Coronary Artery Disease

KIRKLAND, Wash.--(BUSINESS WIRE)--Prevencio, Inc., the leader in artificial intelligence-powered blood tests for cardiovascular disease, today announced that it has been granted patents for its HAR...

Symbol: PRVNC

3 months ago